ENG/中
老虎證券
行情
交易
收費
下載
優惠與活動
幫助
TigerAI
學堂
機構
財富及資產管理人
自營交易機構
介紹經紀商
三方服務商
股權激勵
關於
關於我們
媒體報道
登入
立即註冊
Toggle
澳股
詳情
本頁面由Tiger Trade Technology Pte. Ltd.提供服務
ALGORAE PHARMACEUTICALS LTD
0.016
-0.001
-5.88%
成交量:
347.15萬
成交額:
5.74萬
市值:
2,720.80萬
市盈率:
-26.36
高:
0.017
開:
0.017
低:
0.016
收:
0.017
52周最高:
0.024
52周最低:
0.005
股本:
17.00億
流通股本:
10.47億
量比:
2.56
換手率:
0.33%
股息:
- -
股息率:
- -
每股收益(TTM):
-0.001
每股收益(LYR):
0.000
淨資產收益率:
-47.38%
總資產收益率:
-39.62%
市淨率:
14.40
市盈率(LYR):
-32.06
資料載入中...
總覽
公司
新聞資訊
公告
Algorae製藥公司達成協議 將在澳大利亞和新西蘭推出兩款心血管及代謝疾病仿製藥
美股速递
·
02/09
Algorae Pharmaceuticals - 簽署協議向澳大利亞市場供應化療藥物卡培他濱
美股速递
·
2025/11/27
Algorae Pharmaceuticals - 擬議協議下,公司將在澳新市場推出兩款仿製藥及其他產品
美股速递
·
2025/10/20
{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎證券香港 | 輕鬆買賣美股港股A股/美債/ETF/Crypto/期權期貨","description":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投,即時串流報價與多種工具,立即開戶享更多優惠!","keywords":"老虎證券,老虎證券開戶,老虎證券香港,老虎證券投資,老虎證券美股,老虎證券登錄,證券開戶,證券公司開戶,股票開戶,香港證券公司,香港證券,證券公司,美股投資平台,小額投資理財,投資app,投資平台,股票買賣,買賣股票平台,炒股app,證券app,新手投資","social":{"ogDescription":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投,即時串流報價與多種工具,立即開戶享更多優惠!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/1AI.AU/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"1AI.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"1AI.AU\",,,,,undefined,":{"symbol":"1AI.AU","market":"AU","secType":"STK","nameCN":"ALGORAE PHARMACEUTICALS LTD","latestPrice":0.016,"timestamp":1774415520000,"preClose":0.017,"halted":0,"volume":3471547,"delay":0,"changeRate":-0.058823529411764754,"nameEN":"ALGORAE PHARMACEUTICALS LTD","floatShares":1046585658,"shares":1700498089,"eps":-0.000607,"marketStatus":"未開盤","change":-0.001,"latestTime":"03-25 16:12:00 AEDT","open":0.017,"high":0.017,"low":0.016,"amount":57371,"amplitude":0.058824,"askPrice":0.017,"askSize":10000,"bidPrice":0.016,"bidSize":1711996,"shortable":3,"etf":0,"ttmEps":-0.000607,"tradingStatus":0,"nextMarketStatus":{"tag":"開盤","tradingStatus":0,"beginTime":1774479600000},"marketStatusCode":0,"adr":0,"exchange":"ASX","adjPreClose":0.017,"openAndCloseTimeList":[[1774393200000,1774414800000]],"volumeRatio":2.556924,"lotSize":1,"tradeCurrency":"AUD","auctionPricing":{"symbol":"1AI.AU","preClose":0.017,"auctionPrice":0.016,"auctionVolume":1644991,"auction":3,"marketStatus":"盘后竞价","timestamp":1774415424853}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"1AI.AU\",,,,,undefined,":{"symbol":"1AI.AU","floatShares":1046585658,"roa":"-39.62%","roe":"-47.38%","lyrEps":-0.000499,"volumeRatio":2.556924,"shares":1700498089,"dividePrice":0,"high":0.017,"amplitude":0.058824,"preClose":0.017,"low":0.016,"week52Low":0.005,"pbRate":"14.40","psRate":"-1040.10","week52High":0.024,"institutionHeld":0,"latestPrice":0.016,"committee":0.988386,"eps":-0.000607,"divideRate":0,"volume":3471547,"delay":0,"ttmEps":-0.000607,"open":0.017,"prevYearClose":0.014,"prevWeekClose":0.015,"prevMonthClose":0.017,"prevQuarterClose":0.014,"fiveDayClose":0.015,"twentyDayClose":0.017,"sixtyDayClose":0.014,"dividendGrowthYears":0,"fiveYearAvgDividendRate":0},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/1AI.AU\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"1AI.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"1AI.AU\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1199700351","title":"Algorae製藥公司達成協議 將在澳大利亞和新西蘭推出兩款心血管及代謝疾病仿製藥","url":"https://stock-news.laohu8.com/highlight/detail?id=1199700351","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1199700351?lang=zh_tw&edition=fundamental","pubTime":"2026-02-09 06:04","pubTimestamp":1770588254,"startTime":"0","endTime":"0","summary":"Algorae Pharmaceuticals Ltd宣布已签署一项重要合作协议,计划在澳大利亚与新西兰市场同步上市两款针对心血管疾病和代谢紊乱的通用名药物。\n此次战略布局将显著提升该公司在大洋洲医药市场的竞争力,通过提供高性价比的替代治疗方案,有望缓解当地患者长期用药的经济压力。两款药物的上市也将进一步完善Algorae在慢性病治疗领域的产品矩阵。\n业内人士分析,此次合作将加速仿制药在澳新地区的市场渗透,为Algorae拓展亚太区域业务奠定坚实基础。随着人口老龄化趋势加剧,心血管与代谢疾病药物市场需求持续增长,此举契合区域医疗健康产业的发展方向。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["1AI.AU","BK7067"],"gpt_icon":0},{"id":"1125866279","title":"Algorae Pharmaceuticals - 簽署協議向澳大利亞市場供應化療藥物卡培他濱","url":"https://stock-news.laohu8.com/highlight/detail?id=1125866279","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1125866279?lang=zh_tw&edition=fundamental","pubTime":"2025-11-27 06:01","pubTimestamp":1764194483,"startTime":"0","endTime":"0","summary":"Algorae Pharmaceuticals - 签署协议向澳大利亚市场供应化疗药物卡培他滨","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7067","1AI.AU"],"gpt_icon":0},{"id":"1150849384","title":"Algorae Pharmaceuticals - 擬議協議下,公司將在澳新市場推出兩款仿製藥及其他產品","url":"https://stock-news.laohu8.com/highlight/detail?id=1150849384","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1150849384?lang=zh_tw&edition=fundamental","pubTime":"2025-10-20 06:01","pubTimestamp":1760911268,"startTime":"0","endTime":"0","summary":"Algorae Pharmaceuticals - 拟议协议下,公司将在澳新市场推出两款仿制药及其他产品","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["1AI.AU","BK7067"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":3,"code":"91000000","status":"200"}]}}